ZIPETO, Donato

ZIPETO, Donato  

DIPARTIMENTO DI NEUROSCIENZE, BIOMEDICINA E MOVIMENTO  

Mostra records
Risultati 1 - 20 di 186 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
2. CRISPR/Cas9 to study virus-host interactions 1-gen-2017 Parolini, F.; Mutascio, S.; Serena, M.; Fochi, S.; Romanelli, M. G.; Zipeto, D.
5. CRISPR/Cas9 for the Study of the Interactions between Viruses and Host 1-gen-2017 Parolini, F.; Mutascio, S.; Serena, M.; Fochi, S.; Romanelli, M. G.; Zipeto, D.
A new approach to the development of a broadly neutralizing anti-HIV vaccine 1-gen-2002 Zipeto, Donato; D., Stella; A., Lusso; P., Sironi; F., Bertazzoni; U., Stegmann
A simple method for human cytomegalovirus (HCMV) DNA quantitation in clinical samples 1-gen-1993 Baldanti, F.; Zella, D.; Furione, M.; Zipeto, Donato; Gerna, G.
ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19 1-gen-2020 Zipeto, Donato; Palmeira, Julys da Fonseca; Argañaraz, Gustavo A.; Argañaraz, Enrique R.
Analisi molecolare delle interazioni fra citomegalovirus umano e leucociti 1-gen-1990 Zipeto, Donato; Silini, E.; Parea, M.; Peri, G.; Maccario, R.; Miranda, P.; G., Gerna; G., Milanesi
Analysis of colorectal cancers for human cytomegalovirus presence 1-gen-2009 Bender, Cecilia; Zipeto, Donato; Bidoia, Carlo; Costantini, Silvia; Zamo', Alberto; Menestrina, Fabio; Bertazzoni, Umberto
Association Analysis Between HIV-1 Env and HLA-C Using Bimolecular Fluorescence Complementation 1-gen-2012 Ziglio, Serena; Astone, Dalila; Danesin, Giulia; Racchiolli, Pierpaolo; Blanco, Almudena; Zipeto, Donato
Association analysis between HIV-1 Env and HLAC using bimolecular fluorescence complementation 1-gen-2011 Ziglio, Serena; Astone, Dalila; Danesin, G.; Racchiolli, Pierpaolo; Blanco, A.; Zipeto, Donato
Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first? 1-gen-2020 Mantovani, Elisa; Lugoboni, Fabio; Federico, Angela; Zipeto, Donato; Tamburin, Stefano
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 1-gen-2009 Rossolillo, Paola; Matucci, Andrea; Racchiolli, Pierpaolo; Mainetti, L.; Scarlatti, G.; Zipeto, Donato
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 1-gen-2008 Rossolillo, P.; Matucci, Andrea; Racchiolli, P.; Mainetti, L.; Dispinseri, S.; Scarlatti, G.; Zipeto, Donato
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 1-gen-2009 Astone, Dalila; Rossolillo, Paola; Matucci, Andrea; Racchiolli, Pierpaolo; Ruggiero, A.; Zipeto, Donato
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 1-gen-2008 Rossolillo, P.; Matucci, Andrea; Racchiolli, P.; Mainetti, L.; Dispinseri, S.; Scarlatti, G.; Zipeto, Donato
Cell-based vaccination: rationale for the use of cells co-expressing HIV anv gp120 and HLA class I Cw4 molecules for the induction of neutralizing antibodies 1-gen-2003 Zipeto, Donato; Cosma, A; Le Grand, R; Erfle, V; Siccardi, Ag; Beretta, A.
Cell-based vaccination: rationale for the use of cells co-expressing HIV ENV gp120 and HLA Class I Cw4 molecules for the induction of neutralizing antibodies 1-gen-2003 Zipeto, Donato; D., Cosma; A., Legrand; R., Erfle; V., Siccardi; A. G., Beretta
Characterization of a human cytomegalovirus (HCMV) mutant in the pp150 gene 1-gen-1993 Zipeto, Donato; Baldanti, F.; Percivalle, E.; Gerna, G.; Milanesi, G.
Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells 1-gen-1998 Bodaghi, B.; Jones, T. R.; Zipeto, D.; Vita, C.; Sun, L.; Laurent, L.; Arenzana-Seisdedos, F.; Virelizier, J. -L.; Michelson, S.
CMV DNA in plasma reflects CMV DNA in white blood cells (WBC) but is not related to symptomatic disease 1-gen-1995 Zipeto, Donato; Morris, S.; Hong, C.; Dowling, A.; Wolitz, R.; Merigan, T. C.; Rasmussen, L.
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 1-gen-2006 Turci, Marco; Pilotti, E.; Ronzi, P.; Magnani, G.; Boschini, A.; Parisi, S. G.; Zipeto, Donato; Lisa, A.; Casoli, C.; Bertazzoni, Umberto